Page last updated: 2024-09-04

atazanavir sulfate and Viremia

atazanavir sulfate has been researched along with Viremia in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Antinori, A; Barbarini, G; Bertoli, A; Bini, T; Caramello, P; Ceccherini-Silberstein, F; Di Perri, G; Gianotti, N; Lorenzini, P; Maserati, R; Melzi, S; Micheli, V; Mussini, C; Narciso, P; Perno, CF; Santoro, MM; Torti, C1
Bastow, B; Coffin, JM; DiRienzo, AG; Fletcher, CV; Godfrey, C; Maldarelli, F; Margolis, DM; McKinnon, JE; Mellors, JW; Mollan, K; Palmer, S; Swindells, S; Thal, G; Wiegand, A; Wilkin, TJ; Woodward, W1
Cain, P; Coakley, E; Farthing, C; Gallant, J; Grant, P; Short, W; Taylor, J; Thal, G; Zolopa, A1
Bhatti, L; Farthing, C; Khanlou, H1
Antinori, A; Bertoli, A; Caramello, P; Cargnel, A; Carosi, G; Di Perri, G; Esposito, R; Filice, G; Lazzarin, A; Lorenzini, P; Maserati, R; Moroni, M; Narciso, P; Perno, CF; Rizzardini, G; Santoro, MM1

Trials

3 trial(s) available for atazanavir sulfate and Viremia

ArticleYear
Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy: final 48-week clinical and virologic outcomes.
    The Journal of infectious diseases, 2009, Mar-15, Volume: 199, Issue:6

    Topics: Adult; Anti-HIV Agents; Atazanavir Sulfate; CD4 Lymphocyte Count; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Male; Middle Aged; Oligopeptides; Pilot Projects; Pyridines; Ritonavir; Treatment Outcome; Viremia; Young Adult

2009
Maintaining reduced viral fitness and CD4 response in HIV-infected patients with viremia receiving a boosted protease inhibitor.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Mar-01, Volume: 48, Issue:5

    Topics: Adult; Anti-HIV Agents; Atazanavir Sulfate; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Drug Resistance, Viral; Female; HIV; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Male; Middle Aged; Oligopeptides; Pyridines; Viremia; Virus Replication

2009
Viro-immunologic response to ritonavir-boosted or unboosted atazanavir in a large cohort of multiply treated patients: the CARe Study.
    AIDS patient care and STDs, 2008, Volume: 22, Issue:1

    Topics: Adult; Anti-HIV Agents; Atazanavir Sulfate; Cohort Studies; Drug Synergism; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Italy; Male; Middle Aged; Oligopeptides; Proportional Hazards Models; Pyridines; Ritonavir; Treatment Outcome; Viral Load; Viremia

2008

Other Studies

2 other study(ies) available for atazanavir sulfate and Viremia

ArticleYear
Two different patterns of mutations are involved in the genotypic resistance score for atazanavir boosted versus unboosted by ritonavir in multiple failing patients.
    Infection, 2009, Volume: 37, Issue:3

    Topics: Amino Acid Sequence; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; CD4 Lymphocyte Count; Chi-Square Distribution; Codon; Drug Resistance, Multiple, Viral; Drug Resistance, Viral; Drug Synergism; Female; Genotype; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Logistic Models; Longitudinal Studies; Male; Multivariate Analysis; Mutation; Oligopeptides; Prospective Studies; Pyridines; Ritonavir; RNA, Viral; Treatment Outcome; Viral Load; Viremia

2009
Interaction between atazanavir and fosamprenavir in the treatment of HIV-infected patients.
    Journal of acquired immune deficiency syndromes (1999), 2006, Jan-01, Volume: 41, Issue:1

    Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Carbamates; Drug Administration Schedule; Drug Interactions; Furans; HIV Infections; Humans; Oligopeptides; Organophosphates; Pyridines; Sulfonamides; Treatment Failure; Viremia

2006